Barinthus Biotherapeutics PLC BRNS
Set alert
0.74 USD -0.02 -2.49%
At close · Sep 8
0.74 0.00 -0.57%
After hours · Sep 8, 4:00 PM ET
0.6421 Day range 0.7629
0.801 52-week range 4.16
- YTD
- +5.73%
- 1 year
- -19.82%
- Open
- 0.7443
- Prev close
- 0.759
- Mkt cap
- 44.65M
- Vol
- 376.14K
- Avg vol
- 54.43K
- EPS
- -1.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6421
- High
- 0.7629
- Forward P/E
- -0.62
- Beta
- -0.58
- Short ratio
- 0.19
- Inst. own
- 46.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.16
- 200-d avg
- 1.66
- 1y target
- 7.25
Financial health
Altman Z-Score
-5.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.4×
FY 2019 5y median -0.8× FY 2025
P/S 0.0×
FY 2019 5y median 3.2× FY 2025
P/B 0.4×
FY 2019 5y median 0.4× FY 2025
P/FCF -0.6×
FY 2019 5y median -2.5× FY 2025
EV/EBITDA 0.5×
FY 2019 5y median -0.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -169.2%
FY 2019 5y median -39.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median -454.1% FY 2025
Net Margin 0.0%
FY 2019 5y median -408.0% FY 2025
ROE -89.7%
FY 2019 5y median -39.3% FY 2025
ROIC -58.2%
FY 2019 5y median -39.5% FY 2025
ROA -67.8%
FY 2019 5y median -34.2% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2019 FY 2025
Operating Income 20.3%
FY 2019 FY 2025
EPS (diluted) -5.8%
FY 2019 FY 2025
Free Cash Flow -61.0%
FY 2019 FY 2025
Financial Health
Current Ratio 7.8×
FY 2019 5y median 12.5× FY 2025
Quick Ratio 7.8×
FY 2019 5y median 12.5× FY 2025
Debt / Equity 0.2×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.9×
FY 2019 5y median 1.8× FY 2025
Interest Coverage -1060×
FY 2019 5y median -1060× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31